BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18469487)

  • 1. Prognosis and risk stratification in young papillary thyroid carcinoma patients.
    Kuo SF; Chao TC; Hsueh C; Chuang WY; Yang CH; Lin JD
    Endocr J; 2008 May; 55(2):269-75. PubMed ID: 18469487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneous Prognoses for pT3 Papillary Thyroid Carcinomas and Impact of Delayed Risk Stratification.
    Tavarelli M; Sarfati J; Chereau N; Tissier F; Golmard JL; Ghander C; Lussey-Lepoutre C; Trésallet C; Menegaux F; Leenhardt L; Buffet C
    Thyroid; 2017 Jun; 27(6):778-786. PubMed ID: 28351220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
    Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of papillary thyroid cancer detection among thyroidectomies in Greece between 1991 and 2006.
    Griniatsos J; Tsigris C; Kanakis M; Kaltsas G; Michail O; Dimitriou N; Argyrakopoulou G; Delladetsima I; Kyriakou V; Syriou V; Alexandraki K; Pikoulis E; Giannopoulos A; Kouraklis G; Diamanti-Kandaraki E; Felekouras E
    Anticancer Res; 2009 Dec; 29(12):5163-9. PubMed ID: 20044632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soft tissue invasion of papillary thyroid carcinoma.
    Lin JD; Hsueh C; Chao TC
    Clin Exp Metastasis; 2016 Aug; 33(6):601-8. PubMed ID: 27154220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of thyroid lobectomy for unilateral multifocal papillary carcinoma.
    Huang H; Liu S; Xu Z; Ni S; Zhang Z; Wang X
    Medicine (Baltimore); 2017 Jul; 96(27):e7461. PubMed ID: 28682915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of patient age in papillary thyroid carcinoma with no high-risk features.
    Ito Y; Miyauchi A; Fujishima M; Masuoka H; Higashiyama T; Kihara M; Onoda N; Miya A
    Endocr J; 2022 Sep; 69(9):1131-1136. PubMed ID: 35431281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted management of papillary thyroid carcinoma according to our own risk group classification system: is thyroid lobectomy the treatment of choice for low-risk patients?
    Ebina A; Sugitani I; Fujimoto Y; Yamada K
    Surgery; 2014 Dec; 156(6):1579-88; discussion 1588-9. PubMed ID: 25262223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial Thyroidectomy for Papillary Thyroid Microcarcinoma: Is Completion Total Thyroidectomy Indicated?
    Donatini G; Castagnet M; Desurmont T; Rudolph N; Othman D; Kraimps JL
    World J Surg; 2016 Mar; 40(3):510-5. PubMed ID: 26546190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
    Zaman SU; Awan MS; Sulaiman MA
    Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomy.
    Kuo SF; Chao TC; Chang HY; Hsueh C; Lin CL; Chiang KC; Chuang WY; Chen YC; Lin JD
    Asian J Surg; 2017 May; 40(3):186-192. PubMed ID: 26553529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
    Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Extrathyroidal Extension Invading Only the Strap Muscles in Papillary Thyroid Carcinomas.
    Li G; Li R; Song L; Chen W; Jiang K; Tang H; Wei T; Li Z; Gong R; Lei J; Zhu J
    Thyroid; 2020 Jan; 30(1):57-64. PubMed ID: 31830859
    [No Abstract]   [Full Text] [Related]  

  • 16. Papillary thyroid carcinoma in children: risk factors and complications of disease recurrence.
    Palmer BA; Zarroug AE; Poley RN; Kollars JP; Moir CR
    J Pediatr Surg; 2005 Aug; 40(8):1284-8. PubMed ID: 16080933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High recurrent rate of multicentric papillary thyroid carcinoma.
    Lin JD; Chao TC; Hsueh C; Kuo SF
    Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
    Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
    Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recurrence risk in patients with papillary thyroid cancer through tumor-node-metastasis staging: A single-center observational study in Taiwan.
    Sun JH; Li YR; Chang KH; Liou MJ; Lin SF; Tsai SS; Yu MC; Hsueh C; Chen ST
    Biomed J; 2022 Dec; 45(6):923-930. PubMed ID: 34808423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic outcomes of papillary thyroid carcinomas with tumors more advanced than T1N0M0.
    Lin JD; Lin KJ; Chao TC; Hseuh C; Tsang NM
    Radiother Oncol; 2008 Oct; 89(1):97-104. PubMed ID: 18534700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.